tetraiodothyroacetic acid has been researched along with Metastase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, Y; Hu, F; Huang, X; Liu, X; Meng, T; Tan, Y; Yang, X; Yuan, H; Zhao, Y; Zhu, Y | 1 |
| Chen, L; Li, X; Song, Y; Sun, Y; Xiao, Y; Xing, Y; Zhang, P | 1 |
2 other study(ies) available for tetraiodothyroacetic acid and Metastase
| Article | Year |
|---|---|
Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Integrin alphaVbeta3; Lung Neoplasms; Mice; Mice, Inbred BALB C; Micelles; Neoplasm Metastasis; NF-kappa B; Pentacyclic Triterpenes; Signal Transduction; Thyroxine; Triterpenes | 2018 |
Tetraiodothyroacetic acid and transthyretin silencing inhibit pro-metastatic effect of L-thyroxin in anoikis-resistant prostate cancer cells through regulation of MAPK/ERK pathway.
Topics: Anoikis; Apoptosis; Cell Line, Tumor; Cell Movement; Gene Silencing; Humans; Male; MAP Kinase Signaling System; Neoplasm Metastasis; Neoplasm Proteins; Prealbumin; Prostatic Neoplasms; Signal Transduction; Thyroxine | 2016 |